← Product Code [CFL](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/CFL) · K971353 # DSL ACTIVE NON-EXTRACTION IGF-I ELISA (K971353) _Diagnostic Systems Laboratories, Inc. · CFL · May 12, 1997 · Clinical Chemistry · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/CFL/K971353 ## Device Facts - **Applicant:** Diagnostic Systems Laboratories, Inc. - **Product Code:** [CFL](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/CFL.md) - **Decision Date:** May 12, 1997 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 862.1370 - **Device Class:** Class 1 - **Review Panel:** Clinical Chemistry ## Indications for Use The DSL IGF-I ELISA assay is intended for the quantitative determination of IGF-1 in human serum. The measurement of serum IGF-I is used as a diagnostic aid in the evaluation of growth-related disorders. ## Device Story DSL 10-2800 IGF-I ELISA kit; enzyme-linked immunosorbent assay (ELISA) for quantitative measurement of Insulin-like Growth Factor-I (IGF-I) in human serum. Principle: capture assay; mouse monoclonal antibody to IGF-I immobilized on microtitration wells; IGF-I in samples sandwiched between immobilized antibody and horseradish peroxidase-conjugated anti-IGF-I antibody. Used in clinical laboratory settings by trained personnel. Output: quantitative IGF-I concentration. Clinical utility: diagnostic aid for growth-related disorders. ## Clinical Evidence Bench testing only. Comparative study of 319 patient samples using DSL 10-2800 ELISA and DSL 2800 IRIMA. Linear regression analysis: Y = 0.60(X) + 0.73; correlation coefficient r = 0.82. ## Technological Characteristics Enzyme-linked immunosorbent assay (ELISA) format. Components: microtitration wells coated with mouse monoclonal anti-IGF-I antibody; horseradish peroxidase-conjugated anti-IGF-I antibody. Detection via enzymatic reaction. ## Regulatory Identification A human growth hormone test system is a device intended to measure the levels of human growth hormone in plasma. Human growth hormone measurements are used in the diagnosis and treatment of disorders involving the anterior lobe of the pituitary gland. ## Predicate Devices - DSL 2800 IGF-I IRIMA ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ D. S. L USA 101 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 Diganoslic System's laboratories, Inc. 445 Medic il ' Sen or Boulevard Wabster Texa . 77598-4217 1JSA Tel 281.332.94.70 a: 281.554.4220 Customer Assistance Center Tel 800.231.7970 Fax 281.338.1895 Email niktgi@dslabs.com ## SUMMARY OF SAFETY AND EFFECTIVENESS Name of Device: Classification Name: Analyte Name: Regulatory Class: DSL 10-2800 IGF-I ELISA Kit Enzyme Linked Immunosorbent Assay, IGF-I Insulin-like Growth Factor-l - MAY 1 2 1997 - Submitter: John Willis Diagnostic Systems Laboratories, Inc. 445 Medical Center Boulevard Webster, Texas 77598 Phone: 281-332-9678 May 7, 1997 Date: The DSL Active IGF-1 ELISA kit was developed for the quantitative measuremer t of Insulin-like Growth Factor-I in human serum. This ELISA format is a capture assay. Mouse monoclonal antibody to IGF-I is immobilized to the inner surface of the microtitration wells. IGF-I in the standards or samples is "sandwiched" between this monoclonal and the anti-IGF-I antibody conjugated to the enzyme horseradish peroxidase. The DSL IGF-I ELISA assay is intended for the quantitative determination of IGF-1 in human serum. The measurement of serum IGF-I is used as a diagnostic aid in the evaluation of growth-related disorders. The DSL 10-2800 IGF-I ELISA is substantially equivalent to the DSL 2800 IGF-I IRIMA. These kits have the same intended use. To demonstrate substantial equivalence between the two assays, patient samples (n = 319) were collected and assayed simultaneously by both methods. Samples were chosen based on expected IGF-I levels so that samples with low, intermediate and high levels of IGF-I would be evaluated. Linear regression analysis of the results obtained for the comparison with the IGF-1 assay gave the equation Y =0.60(X) +0.73 with a correlation coefficient of (r) = 0.82. --- **Source:** [https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/CFL/K971353](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/CFL/K971353) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com